HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuharu Kamachi Selected Research

pyrimidine

1/2022Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuharu Kamachi Research Topics

Disease

7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2023 - 12/2020
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2022 - 01/2018
4Neoplasms (Cancer)
10/2023 - 01/2020
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 01/2018
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2021
1Hypoxia (Hypoxemia)
01/2024
1Thrombocytopenia (Thrombopenia)
01/2024
1Disseminated Intravascular Coagulation
01/2024
1Flushing
01/2024
1COVID-19
01/2024
1Immediate Hypersensitivity
01/2024
1Anaphylaxis (Anaphylactic Shock)
01/2024
1Respiratory Sounds (Crackle)
01/2024
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023
1Carcinogenesis
10/2023
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2023
1Proteinuria
01/2023
1Hematuria
10/2022
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021
1BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)
06/2020
1Rheumatoid Arthritis
06/2020
1Crohn Disease (Crohn's Disease)
01/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2019
1Plasmacytoma
03/2018
1Exanthema (Rash)
01/2018

Drug/Important Bio-Agent (IBA)

6Tyrosine Kinase InhibitorsIBA
12/2023 - 12/2020
5DNA (Deoxyribonucleic Acid)IBA
10/2023 - 01/2020
3mogamulizumabIBA
02/2019 - 01/2018
1remdesivirIBA
01/2024
1Dacarbazine (DIC)FDA LinkGeneric
01/2024
1alectinibIBA
10/2023
1Anaplastic Lymphoma KinaseIBA
10/2023
1Histones (Histone)IBA
01/2023
1venetoclaxIBA
01/2023
1DecitabineFDA Link
01/2023
1Azacitidine (5 Azacytidine)FDA Link
01/2023
1CreatinineIBA
01/2023
1Serum AlbuminIBA
01/2023
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022
1OR-2100IBA
01/2022
1EnzymesIBA
01/2022
1Imatinib Mesylate (Gleevec)FDA Link
01/2022
1pyrimidineIBA
01/2022
1MethyltransferasesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
12/2020
1SteroidsIBA
06/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1CC ChemokinesIBA
01/2019
1Monoclonal AntibodiesIBA
01/2019
1Bortezomib (Velcade)FDA Link
03/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018

Therapy/Procedure

2Therapeutics
01/2022 - 01/2020
1Molecular Targeted Therapy
10/2023
1Immunotherapy
10/2022
1Conservative Treatment
10/2022
1Transplantation
01/2022
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2022
1Induction Chemotherapy
06/2020
1Stem Cell Transplantation
01/2020
1Drug Therapy (Chemotherapy)
02/2019
1Hematopoietic Stem Cell Transplantation
03/2018